Omnaris

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Ciclesonide 50ug (per actuation)

Disponible desde:

Chiesi New Zealand Limited t/a Emerge Health

Designación común internacional (DCI):

Ciclesonide 50 µg (per actuation)

Dosis:

50 mcg/dose

formulario farmacéutico:

Nasal spray solution

Composición:

Active: Ciclesonide 50ug (per actuation) Excipient: Carmellose sodium Disodium edetate Hydrochloric acid Hypromellose Microcrystalline cellulose Nitrogen Potassium sorbate Purified water

Unidades en paquete:

Inhaler, metered, Glass bottle with metered dose pump, 60 dose units

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Dynamit Nobel GmbH

indicaciones terapéuticas:

Omnaris® Nasal Spray is indicated for the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.

Resumen del producto:

Package - Contents - Shelf Life: Inhaler, metered, Glass bottle with metered dose pump - 60 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified - Inhaler, metered, Glass bottle with metered dose pump - 120 dose units - 2 years from date of manufacture stored at or below 30°C. Unopened 4 months opened, Not Specified

Fecha de autorización:

2010-06-28